6 U.S. lawmakers have disclosed 14 DexCom, Inc. trades under the STOCK Act — 2 buys and 12 sells between 2017 and 2026. Congress has been net sellers of DXCM, and their disclosed buys are up 24.7% versus the latest close.
*Notional-weighted price return on lawmakers' disclosed buys of DXCM, marked to the latest close — per-share (share counts aren't disclosed).
| Date | Member | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2026-05-07 | Michael T. McCaul | SELL | $1K–$15K | $60.91 | $91.48 2026-08-13 | -50.2% exit |
| 2026-05-07 | Tina Smith | SELL | $100K–$250K | $60.91 | $91.48 2026-08-13 | -50.2% exit |
| 2026-04-29 | Tina Smith | SELL | $100K–$250K | $57.56 | $91.48 2026-08-13 | -58.9% exit |
| 2026-01-26 | John Boozman | BUY | $1K–$15K | $73.34 | $91.48 2026-08-13 | +24.7% |
| 2024-12-31 | Kevin Hern | SELL | $50K–$100K | $77.77 | $91.48 2026-08-13 | -17.6% exit |
| 2022-09-28 | Josh Gottheimer | SELL | $1K–$15K | $83.33 | $91.48 2026-08-13 | -9.8% exit |
| 2020-12-24 | Josh Gottheimer | SELL | $1K–$15K | $88.75 | $91.48 2026-08-13 | -3.1% exit |
| 2020-08-13 | Josh Gottheimer | SELL | $1K–$15K | $108.82 | $91.48 2026-08-13 | +15.9% exit |
| 2020-05-11 | Josh Gottheimer | SELL | $1K–$15K | $105.34 | $91.48 2026-08-13 | +13.2% exit |
| 2020-03-17 | Tina Smith | SELL | $250K–$500K | $49.69 | $91.48 2026-08-13 | -84.1% exit |
| 2019-07-16 | Josh Gottheimer | SELL | $1K–$15K | $37.46 | $91.48 2026-08-13 | -144.2% exit |
| 2019-06-20 | Bradley S. Schneider | SELL | $100K–$250K | $38.91 | $91.48 2026-08-13 | +100.0% rt |
| 2019-06-13 | Josh Gottheimer | SELL | $1K–$15K | $36.58 | $91.48 2026-08-13 | -150.1% exit |
| 2017-06-20 | Bradley S. Schneider | BUY | $100K–$250K | $19.46 | $91.48 2026-08-13 | +370.1% |
Return: buys marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (stock move after the sale, seller's perspective).
6 members of the U.S. House and Senate have disclosed DexCom, Inc. transactions under the STOCK Act — 2 purchases and 12 sales. The full member-by-member breakdown, with dates and dollar ranges, is in the table above.
No member of Congress has disclosed a DXCM purchase in the last 90 days. STOCK Act filings lag the trade by up to 45 days, so newer buys may still be pending disclosure.
Notional-weighted, lawmakers' disclosed DXCM buys are up 24.7% versus the latest close of $91.48. Each trade's own return — and realized round-trips on matched sells — is in the Return column.
Yes. Under the 2012 STOCK Act, members of Congress may buy and sell individual stocks but must publicly disclose each transaction within 45 days. Bargo surfaces those filings so you can see who traded DXCM and how it performed.